ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Takeshi Nakatani
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takano, H.
Right arrow Articles by Nakatani, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takano, H.
Right arrow Articles by Nakatani, T.

Ann Thorac Surg 1996;61:317-322
© 1996 The Society of Thoracic Surgeons


Experience With Devices With Limited Availability

Ventricular Assist Systems: Experience in Japan With Toyobo Pump and Zeon Pump

Hisateru Takano, MD, PhD, Takeshi Nakatani, MD, PhD

National Cardiovascular Center Research Institute, Osaka, Japan

Abstract

Background. Two types of ventricular assist systems have been approved for use by the Japanese government.

Methods. The two government-approved ventricular assist systems, the Toyobo pump (National Cardiovascular Center type) and the Zeon pump (Tokyo University type), were applied to 219 patients in Japan as of October 20, 1994.

Results. Adult-sized were used in 211 patients and pediatric ones in 8 patients. Left ventricular assist systems was performed in most cases (82.6%). The predominant indication was failure to be weaned from cardiopulmonary bypass (65.8%). The duration of ventricular assist system application ranged from 1 hour to 70 days, and the mean was 7.3 days, excluding the patients with cardiomyopathy. The weaning rate was 48.8% and the survival rate was 25.6%. Main causes of death were heart failure including unrecoverable heart failure and multiple organ failure. In 12 cardiomyopathy patients, Toyobo pumps were applied as left ventricular assist systems. Support duration was from 13 days to 192 days (ongoing). One patient was bridged to transplantation successfully and 1 was weaned after 3 months of support.

Conclusions. From these data, the Toyobo pump and the Zeon pump are useful for short-term support for acute, profound heart failure. The Toyobo pump also may provide sufficient support as a bridge to transplantation for the medium term.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
R. M. Suri, R. C. Daly, J. A. Dearani, and C. G.A. McGregor
Successful Use of Thoratec Biventricular Support in a Small Child Awaiting Cardiac Transplantation
Ann. Thorac. Surg., November 1, 2005; 80(5): 1920 - 1922.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Y. Asaumi, S. Yasuda, I. Morii, H. Kakuchi, Y. Otsuka, A. Kawamura, Y. Sasako, T. Nakatani, H. Nonogi, and S. Miyazaki
Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation
Eur. Heart J., October 2, 2005; 26(20): 2185 - 2192.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Kitamura, T. Nakatani, K. Bando, Y. Sasako, J. Kobayashi, and T. Yagihara
Modification of bicaval anastomosis technique for orthotopic heart transplantation
Ann. Thorac. Surg., October 1, 2001; 72(4): 1405 - 1406.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A K Mahmood, J M Courtney, S Westaby, M Akdis, and H Reul
Critical review of current left ventricular assist devices
Perfusion, September 1, 2000; 15(5): 399 - 420.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.